Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Marc A. Attiyeh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9949-1449; OpenAlex author ID A5012791304. Sources: OpenAlex.

Their work

Papers
14 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
61
Papers, trials and grants by year

2017: 3 papers · 2018: 1 paper · 2019: 2 papers · 2020: 3 papers · 2021: 1 paper · 2022: none · 2023: none · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper

Papers 14

  1. NEIL2 regulates RNA polymerase II dynamics to suppress transcription–replication conflicts in pancreatic cancer Co-author DOI 10.64898/2026.10.19.760262↗
  2. The Evolutionary Forest of Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-23-1541↗
  3. Patterns of Failure in Patients With Borderline Resectable/Locally Advanced Pancreatic Cancer After Preoperative Chemotherapy and Stereotactic Body Radiation T… Co-author DOI 10.1016/j.adro.2024.101471↗
  4. Base-excision repair pathway regulates transcription-replication conflicts in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.celrep.2024.114820↗
  5. Multidisciplinary management of locally advanced pancreatic adenocarcinoma: Biology is King. Co-author DOI 10.1002/jso.26415↗
  6. A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s43018-019-0010-1↗
  7. Evolutionary Dynamics of Non-Coding Regions in Pancreatic Ductal Adenocarcinoma Co-author DOI 10.1101/2020.09.11.294389↗
  8. The Evolutionary Origins of Recurrent Pancreatic Cancer. First author DOI 10.1158/2159-8290.cd-19-1508↗
  9. CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00261-019-02112-1↗
  10. The Genetic Basis of Transcriptional and Spatial Heterogeneity of Squamous Features in Pancreatic Ductal Adenocarcinoma Co-author DOI 10.1101/548354↗
  11. Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis. Co-author DOI 10.1245/s10434-017-6323-3↗
  12. Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer. Co-author DOI 10.1038/nature24462↗
  13. Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer. Co-author DOI 10.1038/ng.3764↗
  14. An unusual genomic variant of pancreatic ductal adenocarcinoma with an indolent clinical course. Co-author DOI 10.1101/mcs.a001701↗

Closest collaborators

The 25 strongest of 61 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christine A. Iacobuzio–Donahue · 9 shared papers, 2017–2025 · strength 0.76
  2. Alvin P. Makohon-Moore · 7 shared papers, 2017–2025 · strength 0.64
  3. Jungeui Hong · 6 shared papers, 2017–2025 · strength 0.57
  4. Akimasa Hayashi · 5 shared papers, 2019–2025 · strength 0.52
  5. Laura DeLong Wood · 5 shared papers, 2017–2025 · strength 0.48
  6. Zachary A. Kohutek · 5 shared papers, 2017–2025 · strength 0.47
  7. Fan Meng · 2 shared papers, 2024–2026 · strength 0.43
  8. Terence Marques Williams · 2 shared papers, 2024–2026 · strength 0.43
  9. Mustafa Raoof · 2 shared papers, 2024–2026 · strength 0.43
  10. Hitomi Sakamoto · 4 shared papers, 2019–2025 · strength 0.43
  11. Ralph H. Hruban MD · 4 shared papers, 2017–2020 · strength 0.28
  12. Caitlin A. McIntyre · 2 shared papers, 2019–2025 · strength 0.27
  13. Olca Baştürk · 4 shared papers, 2017–2020 · strength 0.27
  14. Eileen Mary O'Reilly · 3 shared papers, 2020 · strength 0.25
  15. Jen Jen Yeh · 1 shared paper, 2026 · strength 0.24
  16. David W. Dawson · 1 shared paper, 2026 · strength 0.24
  17. Johannes G. Reiter · 3 shared papers, 2017–2020 · strength 0.23
  18. Eric M. Chung · 1 shared paper, 2024 · strength 0.20
  19. Andrew Eugene Hendifar · 1 shared paper, 2024 · strength 0.20
  20. Alexandra Gangi · 1 shared paper, 2024 · strength 0.20
  21. Mitchell R. Kamrava · 1 shared paper, 2024 · strength 0.20
  22. Nicholas N. Nissen · 1 shared paper, 2024 · strength 0.20
  23. Jun Gong · 1 shared paper, 2024 · strength 0.20
  24. Arsen Osipov · 1 shared paper, 2024 · strength 0.20
  25. Katelyn Mullen · 1 shared paper, 2025 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.